According to Revance Therapeutics's latest financial reports the company's current earnings (TTM) are -S$0.35 B. In 2023 the company made an earning of -S$0.39 B an increase over its 2022 earnings that were of -S$0.45 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.